Bristol Myers – BOL News Staging

Due to delayed cancer medicine, Bristol Myers will be sued for $6.4 billion

June 25, 2022 by Maryam nadeem

A U.S. judge refuses to dismiss a $6.4 billion lawsuit against Bristol Myers Squibb. Trustee says drugmaker delayed cancer drug approval to avoid payments to shareholders. Former Celgene Corp was bought by Bristol Myers in 2019 for $80.3 billion. A U.S. judge on Friday would not excuse a $6.4 billion claim blaming Bristol Myers Squibb … Read more

Therapeutics, Lululemon, RH are among the stocks that made changes

June 4, 2022 by Salman farooqui

Bristol Myers Squibb has agreed to buy biopharmaceutical company Turning Point Therapeutics for $4.1 billion. Lululemon shares rose 1% in premarket trading after the athletic apparel maker reported a better-than-expected quarter. CrowdStrike (CRWD) – CrowdStrike fell 4.3% in premarket activity despite the fact that the network safety organization posted surprisingly good outcomes for its most … Read more

Menu

Latest

Entertainment

Lifestyle